Familial Pancreatic Cancer PROPHilation Program in Italy

Recruiting now · Not applicable

Conditions studied: Candidates for Hereditary Pancreatic Cancer Testing

In brief

The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.

Key facts

Study ID

NCT05724992

Run by

Associazione Italiana per lo Studio del Pancreas

People needed

3000

Starts

2022-12-20

Expected to finish

2028-12-20

Last updated by the study team

2023-02-15

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Being enrolled on the IRFARPC registry
• Having familiarity for pancreatic cancer (according to the IRFARPC criteria, Capurso et al. Dig Liv Dis, 2020)
• Willingness to participate in saliva-swab-based genetic testing

You may not qualify if…

• Already known genetic mutation

Where it is running

• Chirurgia generale e del Pancreas Azienda Ospedaliera Universitaria Integrata — Verona, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.